Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Critical Reviews in Oncology/Hematology
|
May 22, 2019
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives
Claudio Vernieri, Monica Milano, Marta Brambilla, et al.
Tumori
|
May 5, 2026
The impact of bio-psycho-social factors on mental health outcomes in patients with solid tumors
Raffaela D G Sartori, Davide Dalu, Davide De Francesco, et al.
The Pharmacogenomics Journal
|
March 2, 2021
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients
Sara Demurtas, Nicla La Verde, Selene Rota, et al.
Clinical Breast Cancer
|
January 13, 2019
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles
Claudio Vernieri, Michele Prisciandaro, Monica Milano, et al.
Scientific Reports
|
June 9, 2018
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Patient Journey for Triple-Negative Breast Cancer: Optimal Care Pathways vs. Reality of Care in Italian Breast Units
Nicla La Verde, Luisa Brogonzoli, Maria Silvia Cona, et al.
Cancers
|
February 17, 2019
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies
Maria Silvia Cona, Mara Lecchi, Sara Cresta, et al.
Tumori
|
October 21, 2015
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
Diego Signorelli, Marianna Macerelli, Claudia Proto, et al.
Vaccines
|
June 27, 2024
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience
Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, et al.
International Journal of Cancer
|
December 15, 2023
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients
Davide Dalu, Maciej Tarkowski, Lorenzo Ruggieri, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Critical Reviews in Oncology/Hematology
|
May 22, 2019
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives
Claudio Vernieri, Monica Milano, Marta Brambilla, et al.
Tumori
|
May 5, 2026
The impact of bio-psycho-social factors on mental health outcomes in patients with solid tumors
Raffaela D G Sartori, Davide Dalu, Davide De Francesco, et al.
The Pharmacogenomics Journal
|
March 2, 2021
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients
Sara Demurtas, Nicla La Verde, Selene Rota, et al.
Clinical Breast Cancer
|
January 13, 2019
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles
Claudio Vernieri, Michele Prisciandaro, Monica Milano, et al.
Scientific Reports
|
June 9, 2018
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Patient Journey for Triple-Negative Breast Cancer: Optimal Care Pathways vs. Reality of Care in Italian Breast Units
Nicla La Verde, Luisa Brogonzoli, Maria Silvia Cona, et al.
Cancers
|
February 17, 2019
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies
Maria Silvia Cona, Mara Lecchi, Sara Cresta, et al.
Tumori
|
October 21, 2015
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
Diego Signorelli, Marianna Macerelli, Claudia Proto, et al.
Vaccines
|
June 27, 2024
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience
Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, et al.
International Journal of Cancer
|
December 15, 2023
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients
Davide Dalu, Maciej Tarkowski, Lorenzo Ruggieri, et al.
Page
of 3